文献速递神经肿瘤

分子分型在胶质瘤手术中的意义

Implications of molecular classifications in glioma surgery.
PubMed 文献 · J Neurooncol · 2024-11-12

本文综述神经外科与神经肿瘤学文献,探讨成人弥漫性胶质瘤三种分子亚型(IDH野生型胶质母细胞瘤、IDH突变型星形细胞瘤、IDH突变伴1p/19q共缺失少突胶质细胞瘤)的手术策略与切除范围,并讨论分子标志物指导手术决策的实用价值。

要点

  • 成人弥漫性胶质瘤按分子标志物分为三种亚型:IDH野生型胶质母细胞瘤、IDH突变型星形细胞瘤、IDH突变伴1p/19q共缺失少突胶质细胞瘤。
  • 手术切除是许多胶质瘤患者的主要治疗手段,但手术管理策略需在特征性分子谱背景下重新探讨。
  • 术前与术中分子诊断的进步将提升分子生物标志物在指导胶质瘤患者手术决策中的效用。

核心结论

  • 分子标志物与手术干预的相关性日益增强,术前和术中分子诊断的进步将增加分子生物标志物在指导胶质瘤手术决策中的效用。

研究设计与样本

  • 综述神经外科与神经肿瘤学文献,纳入在分子定义的成人弥漫性胶质瘤队列中研究手术的相关研究。

主要发现

  • 讨论了与成人弥漫性胶质瘤三种亚型相关的关键分子标志物:IDH野生型胶质母细胞瘤、IDH突变型星形细胞瘤、IDH突变伴1p/19q共缺失少突胶质细胞瘤。
  • 讨论了这些肿瘤的手术策略与切除范围,并将其置于关键分子改变的背景下进行阐述。
  • 简要讨论了分子标志物在指导手术决策中的实用价值。

临床怎么用

  • 分子标志物与手术干预的相关性日益增强,术前和术中分子诊断的进步将增加分子生物标志物在指导胶质瘤手术决策中的效用。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The incorporation of molecular markers into neuro-oncology has transformed our understanding of adult diffuse gliomas. While surgical resection is the mainstay of treatment for many patients with gliomas, surgical management strategies warrant re-exploration in the context of characteristic molecular profiles. METHODS: We reviewed the neurosurgical and neuro-oncological literature for studies investigating surgery in molecularly defined cohorts of adult diffuse gliomas. RESULTS: We discuss key molecular markers associated with the three subtypes of adult diffuse glioma: glioblastoma IDH-wildtype, astrocytoma IDH-mutant, and oligodendroglioma IDH-mutant and 1p/19q codeleted. We additionally discuss surgical strategies and extent of resection in these tumors, framing them in the context of key molecular alterations. Finally, we briefly discuss the practical utility of molecular markers in guiding surgical decision making. CONCLUSION: Molecular markers in gliomas are of growing relevance to surgical intervention. Advancements in preoperative and intraoperative molecular diagnostics will increase the utility of molecular biomarkers in informing surgical decision-making for patients with gliomas.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Kalluri AL, Lee JH, Lucas CG, et al. Implications of molecular classifications in glioma surgery. J Neurooncol. 2024. PMID: 39532825. doi:10.1007/s11060-024-04883-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。